Bullous pemphigoid — ABIM Board MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Begin serial phlebotomy while addressing iron and susceptibility factors
The best answer is “Begin serial phlebotomy while addressing iron and susceptibility factors”. Porphyria cutanea tarda results from hepatic uroporphyrinogen-decarboxylase inhibition and is often promoted by iron excess, alcohol, estrogen, hepatitis-C infection or HIV. In a nonanemic patient, serial phlebotomy lowers hepatic iron and porphyrin production while reversible contributors are treated. Low-dose hydroxychloroquine is an alternative when phlebotomy is unsuitable; intravenous hemin is used for acute hepatic porphyria rather than this chronic cutaneous disorder.
Reference: AASLD Clinical Liver Disease Review: Porphyria Cutanea Tarda: https://pmc.ncbi.nlm.nih.gov/articles/PMC11665602/